Showing 1 to 10 of 34 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants With Hematologic Malignancies
MK-1026-003 NCT04728893  Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma |
Dr. Isabelle Fleury Nawel Mechtouf 514-252-3400 poste 4681 |
|
A Multicenter, Open-label, Phase 2 Basket Study to Evaluate the Safety and Efficacy of MK-2140 as a Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies
MK-2140-006 NCT05458297 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Chronic Lymphocytic Leukemia Non-Hodgkin's Lymphoma |
Dr. Sarit Assouline Edrian Gabrielle Bumanlag 514-840-8222 poste 23638 |
|
A Phase I/II Open-label Study of the Safety and Efficacy of Epstein-Barr Virus Specific T-cell Lines for the Treatment of EBV Infection or EBV-related Lymphoproliferative Diseases
EBV-TCL-01 NCT02580539 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Non-Hodgkin's Lymphoma |
Dr. Jean-Sébastien Delisle Stéphanie Thiant 514-252-3400 poste 4681 |
|
Un registre de données cliniques et paracliniques, incluant une banque de tissus biologiques, de patients atteints d’un lymphome (Registre des lymphomes)
HMR-LYM001 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Non-Hodgkin's Lymphoma |
Dr. Isabelle Fleury Michel-Olivier Gratton 514-252-3400 poste 2397 |
|
A Phase I/II Trial Investigating Safety and Efficacy of Autologous TAC T Cells Targeting CD19 in Relapsed or Refractory Large B-Cell Lymphoma
TAC01-CD19-01 NCT03880279 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Non-Hodgkin's Lymphoma |
Dr. Isabelle Fleury Michel-Olivier Gratton 514-252-3400 poste 2397 |
|
A Phase 1, Multicenter, Open-label, Dose Finding Study of CC-96673 in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
CC-96673-NHL-001 NCT04860466 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Non-Hodgkin's Lymphoma |
Dr. Sarit Assouline |
|
A Phase Ib/II, Open-Label, Multicenter, Randomized, Controlled Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Patients With B-Cell Non-Hodgkin Lymphoma
GO40515 NCT03677141 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Non-Hodgkin's Lymphoma |
Dr. Sarit Assouline Aline Khayat 514-340-8222 |
|
A Phase 2, Open-label, Single Arm, Multicenter Trial to Evaluate the Safety and Efficacy of JCAR017 (Lisocabtagene Maraleucel) in Adult Subjects With High-risk, Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
TRANSCEND FL NCT04245839 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Non-Hodgkin's Lymphoma |
Dr. Isabelle Fleury Olivier Cormier 514-252-3400 poste 5966 |
|
A Phase 2 Study of Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary Central Nervous System Lymphoma
I244 NCT05998642 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Non-Hodgkin's Lymphoma |
Dr. Jean-François Larouche Philippe Nadeau 418-649-0252 poste 63115 |
|
A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase Targeted Protein Degrader BGB-16673 in Patients With B-Cell Malignancies
BGB-16673-101 NCT05006716 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS
|
Non-Hodgkin's Lymphoma |
Dr. Olivier Dumas Maryse Gingras 418-525-4444 poste 67322 |
Groupe d'étude en oncologie du Québec